Literature DB >> 25223875

Decade in review-HCV: hepatitis C therapy-a fast and competitive race.

Stefan Zeuzem1.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25223875     DOI: 10.1038/nrgastro.2014.164

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  3 in total

Review 1.  Treatment Options in Hepatitis C.

Authors:  Stefan Zeuzem
Journal:  Dtsch Arztebl Int       Date:  2017-01-09       Impact factor: 5.594

Review 2.  [Chronic hepatitis C : Standard treatment and remaining challenges].

Authors:  S Zeuzem
Journal:  Internist (Berl)       Date:  2018-06       Impact factor: 0.743

3.  Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.

Authors:  Shanshan He; Jingbo Xiao; Andrés E Dulcey; Billy Lin; Adam Rolt; Zongyi Hu; Xin Hu; Amy Q Wang; Xin Xu; Noel Southall; Marc Ferrer; Wei Zheng; T Jake Liang; Juan J Marugan
Journal:  J Med Chem       Date:  2016-02-01       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.